Page 76 - CIBERSAM2016-ENG

leaD reSearcHer
Pérez Sola, Víctor
Consorci Mar Parc Salut
de Barcelona
Consorcio Mar Parc de Salut de Barcelona
Dr. Aiguader, 88, 1a Pl. 08003 Barcelona
(+34) 607 664 285 [email protected] group website
GROUP MEMBERS
Staff members: Allende Leal, Saiko | Blanco Hinojo, Laura | Elices, Matilde | Grasa Bello, Eva María | Pujol Nuez, Jesús
Associated members: Alonso Solís, Ana | Álvarez Martínez, Enrique | Antonijoan Arbos, Rosa María | Arranz Calderón, María Jesús | Berge Baquero, Daniel | Bulbena Vilarrasa, Antonio | Carceller Sindreu, María del Mar | Clos Batet, Susana | Colom Victoriano, Francesc | Córcoles Martínez, David | Corripio Collado, Iluminada | De Diego Adeliño, Francisco Javier | Durán-Sindreu Terol, Santiago | Fullana Rivas, Miquel Ángel | Giménez Badía, Sandra | Martín Blanco, Ana | Martín López, Luis Miguel | Oller Canet, Sílvia | Pascual Mateos, Juan Carlos | Pérez Blanco, Josefina | Pérez de los Cobos Peris, José | Pérez Egea, Rosario | Portella Moll, María Jesús | Puigdemont Campos, Dolors | Rabella Figueras, Mireia | Ramos Ferraz, Liliana | Riba Serrano, Jordi | Sauras Quetcuti, Rosa Blanca | Serra Blasco, María | Soler Ribaudí, Joaquín | Tiana Sastre, Thais | Toll Privat, Alba | Trujols Albet, Joan | Valle Cano, Marta
Contributors: Ballester Verneda, María Rosa | Gich Saladich, Ignacio José | Romero Lafuente, Sergio
Main lines of research
Permanent research lines:
• Affective disorders: new therapeutic strategies in treatment-resistant major depression; Deep Brain Stimulation in Treatment Resistant Major Depression; structural neuroimaging; treatment resistance biological and genetic biomarkers; biological and genetic studies of inflammatory processes in major depression; identification and evaluation of new therapeutic targets and programs; pharmacogenetics;
ICT application and new technologies in the prevention and treatment of depression and bipolar disorder; assessment of traumatic processes in affective disorders and treatment using psychotherapeutic techniques, e.g. EMDR; assessment of therapeutic strategies in suicidal behavior.
• Psychotic disorders: efficacy and effectiveness of antipsychotic drugs; first episodes of psychosis; genotype- phenotype and environment interaction; neuroimaging; pharmacogenetics; ICT and Apps in m-health for treatment resistant schizophrenia; Deep Brain Stimulation in Treatment Resistant Schizophrenia; third generation therapies for the treatment of schizophrenia (metacognition and mentalization); assessment of the possible beneficial effect of physical activity and intensive reemployment programs in first psychotic episodes.
76
PROGRAMMES
Depression
Psychosomatic, Anxiety
and Impulse Control Disorders